Christine Erikstrup Hallgreen

Christine Erikstrup Hallgreen

Lektor

Medlem af:


    1. 2023
    2. Udgivet

      Impact of 2018 EU Risk Minimisation Measures and Revised Pregnancy Prevention Programme on Utilisation and Prescribing Trends of Medicinal Products Containing Valproate: An Interrupted Time Series Study

      Abtahi, S., Pajouheshnia, R., Durán, C. E., Riera-Arnau, J., Gamba, M., Alsina, E., Hoxhaj, V., Andersen, M., Bartolini, C., Kristiansen, S. B., Brown, J., Hallgreen, C. E., Garcia-Poza, P., Gardarsdottir, H., Gini, R., Girardi, A., Holthuis, E., Huerta, C., Ibánez, L., Limoncella, G. & 8 flere, Martín-Pérez, M., Paoletti, O., Roberto, G., Souverein, P., Swart, K. M. A., Wing, K., Sturkenboom, M. & Klungel, O., 2023, I: Drug Safety. 46, 7, s. 689-702

      Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

    3. Under udarbejdelse

      Clinical evidence and use of extrapolation in European biosimilar marketing authorizations

      Druedahl, Louise C., Vive Nielsen, C. & Hallgreen, Christine Erikstrup, 2023, (Under udarbejdelse) I: BioDrugs.

      Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

    4. Udgivet

      Impact of the 2018 revised Pregnancy Prevention Programme by the European Medicines Agency on the use of oral retinoids in females of childbearing age in Denmark, Italy, Netherlands, and Spain: an interrupted time series analysis

      Durán, C. E., Riera-Arnau, J., Abtahi, S., Pajouheshnia, R., Hoxhaj, V., Gamba, M., Alsina, E., Martin-Perez, M., Garcia-Poza, P., Llorente-Garcia, A., Gonzalez-Bermejo, D., Ibánez, L., Sabaté, M., Vidal, X., Ballarín, E., Sanfélix-Gimeno, G., Rodríguez-Bernal, C., Peiró, S., García-Sempere, A., Sanchez-Saez, F. & 22 flere, Ientile, V., Ingrasciotta, Y., Guarneri, C., Tanaglia, M., Tari, M., Herings, R., Houben, E., Swart-Polinder, K., Holthuis, E., Huerta, C., Gini, R., Roberto, G., Bartolini, C., Paoletti, O., Limoncella, G., Girardi, A., Hyeraci, G., Andersen, Morten, Kristiansen, S. B., Hallgreen, Christine Erikstrup, Klungel, O. & Sturkenboom, M., 2023, I: Frontiers in Pharmacology. 14, 12 s., 1207976.

      Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

    5. Udgivet

      Regional Disparity in First-in-Class Anticancer Drug Development in the US, EU, and Japan

      Hino, Y., Okada, M., Hallgreen, Christine Erikstrup, De Bruin, M. L., Doty, R. E., Matsumaru, N. & Tsukamoto, K., 2023, I: Biological and Pharmaceutical Bulletin. 46, 5, s. 700-706

      Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

    6. Afsendt

      Implementation of electronic distribution of Direct Healthcare Professional Communications (DHPCs) by the Danish Medicines Agency: A survey study of physicians’ experiences and preferences

      Sindahl, P., Møllebæk, Mathias, Gardarsdottir, H., De Bruin, M. L. (., Hallgreen, Christine Erikstrup & Clemmensen, M. H., 2023, (Afsendt) I: Therapeutic Advances in Drug Safety.

      Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

    7. 2022
    8. Udgivet

      Flash presentation: Impact of 2018 EU Risk Minimisation Measures and Revised Pregnancy Prevention Programme on Utilisation and Prescribing Trends of Valproates

      Abtahi, S., Pajouheshnia, R., Duran-Salinas, C., Riera-Arnau, J., Gamba, M., Alsina, E., Hallgreen, Christine Erikstrup, Limoncella, G., Bartolini, C., Holthuis, E., Martin-Perez, M., Brown, J., Sturkenboom, M., Klungel, O. & Lot, O., 2022, I: Drug Safety. 45, 10, s. 1312-1313

      Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningfagfællebedømt

    9. Udgivet

      Guidance for pediatric use in prescription information for novel medicinal products in the EU and the US

      Christiansen, H., De Bruin, M. L., Frøkjær, Sven & Hallgreen, Christine Erikstrup, 2022, I: PLoS ONE. 17, 4, 19 s., e0266353.

      Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

    10. Udgivet

      Mandatory requirements for pediatric drug development in the EU and the US for novel drugs: A comparative study

      Christiansen, Helle, De Bruin, M. L. & Hallgreen, Christine Erikstrup, 2022, I: Frontiers in Medicine. 9, 11 s., 1009432.

      Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

    11. Udgivet

      Status of Planned and Ongoing Paediatric Trials Investigating COVID-19 Vaccines: A Cross-Sectional Study of Paediatric Clinical Trials Planned in Agreed PIPs and/or Registered in Clinical Trial Databases

      Christiansen, H., Thirstrup, Steffen & Hallgreen, Christine Erikstrup, 2022, I: Therapeutic Innovation & Regulatory Science. 56, s. 474–482

      Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

    12. Udgivet

      Marketing authorization pathways and clinical evidence supporting approval of orphan medicinal products in EU between January 2015 and October 2021

      Hallgreen, Christine Erikstrup, Møllebæk, Mathias & Corap, E., 2022, I: Pharmacoepidemiology and Drug Safety. 31, S2, s. 266-267

      Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningfagfællebedømt

    Forrige 1 2 3 4 Næste

    ID: 122745397